1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
699D377F2C5AB41AF00258D8000010EC7
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?OpenForm&Query=(clinical+and+trial)+and+(field+ItemCatalog=BMR)&SearchWV=1&sort=relevance&Start=1&Count=10&AQ=clinical+trial
18
19OpenForm&Query=(clinical+and+trial)+and+(field+ItemCatalog=BMR)&SearchWV=1&sort=relevance&Start=1&Count=10&AQ=clinical+trial
2018.97.9.170
21
22
23best-in-class.com
24/bestp/domrep.nsf
25BMR




Search Results

Results 1 - 10 of 400 Total Hits, Sorted by Relevance.

    |    

Best Practices for Managing Clinical Trials During and Beyond the COVID-19 PandemicDirect access to this research is not included with your membership level.

The COVID-19 pandemic has altered clinical trials timelines and protocols for many pharmaceutical companies, but technological advancements have enab... (ID CM-9)
Companies Profiled: Alcon, Alnylam Pharmaceuticals, Aptus Clinical, Atara Biotherapeutics, more ...

Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies To Ensure Medical Device Success in a Global MarketplaceDirect access to this research is not included with your membership level.

In the face of cost and regulatory pressures, clinical programs at medical device organizations have looked to less expensive and regulated areas of the world to perform clinical trial activities... (ID POP-238)
Companies Profiled: Abbott Vascular, Medrad, Medtronic, Boston Scientific, more ...

Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies for Pharmaceutical Success in a Global MarketplaceDirect access to this research is not included with your membership level.

In the face of cost and regulatory pressures, clinical programs at pharmaceutical organizations have looked to less expensive and regulated areas of the world to perform clinical trial activities... (ID POP-239)
Companies Profiled: Eisai, Abbott, Daiichi Sankyo, Merck Serono, more ...

Best Practices in the Oversight and Management of Investigator-Initiated Trials in OncologyDirect access to this research is not included with your membership level.

As the number of investigator initiated trial (IIT) submissions continues to rise for Oncology drug candidates, it has become a critical operational ... (ID POP-341)
Companies Profiled: Becton Dickinson, Bayer, Cipla, Daiichi Sankyo, more ...

Innovation in Combo Product Clinical Development – Harnessing Patient Insights from Reported Usability OutcomesDirect access to this research is not included with your membership level.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

As the healthcare industry gravitates toward increased patient centricity in an all-out effort to achieve the best possible health outcomes, it follo... (ID POP-308)
Companies Profiled: Novartis, Windtree Therapeutics, EMD Serono, Merck, more ...

Best Practices in Distributing Medical Info to Investigators and Physicians through Investigator Portals and Other MeansDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Effective Medical Information groups must evaluate and prioritize how they disseminate critical information to a variety of key external stakeholders... (ID POP-329)
Companies Profiled: AbbVie, Allergan, Alnylam Pharmaceuticals, Boehringer Ingelheim, more ...

Managing Market Planning for New Oncology ProductsDirect access to this research is not included with your membership level.

Understand how leading pharmaceutical companies effectively manage market planning for oncology products during Phase II and Phase III... (ID PSM-205)

$628.00

Clinical Trial Excellence: Toolkit for Winning Investigators in a Competitive MarketplaceDirect access to this research is not included with your membership level.

Market competition is mounting to win the time, attention and interest of the most qualified clinical investigators... (ID OP-105)
Companies Profiled: ALTANA Pharmaceuticals, 3M Pharmaceuticals, Amersham Health, Amgen, more ...

How Strong Medical Affairs Teams Use RWE to Achieve Impact along Patient, Disease State, Clinical and Payer FrontsDirect access to this research is not included with your membership level.

The demand for real world evidence (RWE) has skyrocketed among key stakeholders across the entire healthcare value chain: physicians, thought leaders... (ID POP-330)
Companies Profiled: Adamas Pharmaceuticals, ADC Therapeutics, Agios, Almirall, more ...

Pharma’s Digital Transformation Turning Point: Disruption, Challenges and Recommendations for Medical and Commercial LeadersDirect access to this research is not included with your membership level.

While the COVID-19 pandemic has upended nearly every aspect of the biopharma engagement model, it has also brought about the long-awaited digital transformation of the industry... (ID PSM-367)
Companies Profiled: Abbott, AbbVie, ADC Therapeutics, Advanced Accelerator Applications, more ...